Journal
Clinical and Vaccine Immunology
Publication Date
2016
Volume
23
Issue
9
Inclusive Pages
774-784
Document Type
Open Access Publication
DOI
10.1128/CVI.00730-15
Rights and Permissions
Schmidt DJ, Beamer G, Tremblay JM, Steele JA, Kim HB, Wang Y, Debatis M, Sun X, Kashentseva EA, Dmitriev IP, Curiel DT, Shoemaker CB, Tzipori S. 2016. A tetraspecific VHH-based neutralizing antibody modifies disease outcome in three animal models of Clostridium difficile infection. Clin Vaccine Immunol 23:774–784. doi:10.1128/CVI.00730-15. Copyright © 2016 Schmidt et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
Recommended Citation
Schmidt, Diane J.; Beamer, Gillian; Tremblay, Jacqueline M.; Steele, Jennifer A.; Kim, Hyeun Bum; Wang, Yaunkai; Debatis, Michele; Sun, Xingmin; Kashentseva, Elena A.; Dmitriev, Igor P.; Curiel, David T.; Shoemaker, Charles B.; and Tzipori, Saul, "A tetraspecific VHH-based neutralizing antibody modifies disease outcome in three animal models of Clostridium difficile infection." Clinical and Vaccine Immunology. 23, 9. 774-784. (2016).
https://digitalcommons.wustl.edu/open_access_pubs/5294
Table S1. Mouse systemic toxin challenge. Table S2. C. difficile infection in hamsters. Fig. S1. VNA2-Tcd purification. Fig. S2. VNA2-Tcd detection and neutralizing activity in serum. Fig. S3. VNA2-Tcd detection in hamsters.
